Dr. Joseph Nezgoda, M. D.
What this data tells you about Dr. Nezgoda
Dr. Joseph Nezgoda is an ophthalmology in West Palm Beach, FL, with 17 years in practice. Based on federal Medicare data, Dr. Nezgoda performed 17,931 Medicare services across 3,413 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nezgoda received a total of $570,286 from 51 pharmaceutical and/or device companies across 695 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nezgoda is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) | 6,121 | $29 | $75 |
| Retinal imaging (OCT scan) | 2,333 | $31 | $72 |
| Comprehensive eye exam, established patient | 2,267 | $97 | $197 |
| Eye injection for retinal disease | 1,430 | $93 | $369 |
| 2d ultrasound scan of eye tissue and structures | 1,139 | $35 | $189 |
| Compounded drug, not otherwise classified | 1,111 | $66 | $222 |
| Steroid injection (triamcinolone) | 1,021 | $1 | $49 |
| Injection, ranibizumab, 0.1 mg | 792 | $177 | $468 |
| Extended exam of the back part of the eye with retinal drawing | 393 | $19 | $60 |
| Injection of drug or substance into membrane covering eyeball | 304 | $42 | $232 |
| Retinal photography (fundus photo) | 203 | $29 | $119 |
| Eye exam, established patient, focused | 143 | $70 | $109 |
| Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | 135 | $201 | $784 |
| Comprehensive eye exam, new patient | 104 | $106 | $177 |
| Exam of visual field with intermediate testing | 103 | $36 | $143 |
| Unclassified drugs | 78 | $547 | $1,626 |
| Closure of tear duct opening using plug | 75 | $80 | $201 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 42 | $110 | $220 |
| Destruction of growth of retina using a laser | 39 | $403 | $1,587 |
| New patient office visit (45-59 min) | 26 | $135 | $349 |
| Visual field test, extended | 23 | $48 | $117 |
| Photography of content of eyes | 23 | $19 | $59 |
| Optic nerve imaging (OCT scan) | 14 | $22 | $86 |
| Destruction of eye fluid (vitreous) between lens and retina and all of retina using a laser | 12 | $787 | $3,495 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for ophthalmology in FL.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Nezgoda is a mixed practice specialist, with above-average Medicare volume (top 8% in FL), and high industry engagement (speaking/promotional, top 1%), with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Nezgoda experienced with eye injection (vabysmo/faricimab)?
Does Dr. Nezgoda receive payments from pharmaceutical companies?
How do Dr. Nezgoda's costs compare to other ophthalmologys in West Palm Beach?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology